Eurosurv. Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activit

[tetano]

• Patrick WG Mallon[SUP]1[/SUP] , Mary Horgan[SUP]2[/SUP] , Conor G McAloon[SUP]3[/SUP] , Peter D Lunn[SUP]4[/SUP] , Julian Little[SUP]5[/SUP] , Andrew Beck[SUP]5[/SUP] , Alexandria Bennett[SUP]5[/SUP] , Nicole Shaver[SUP]5[/SUP] , Aileen McConway[SUP]6[/SUP] , Rhea O’Regan[SUP]6[/SUP] , Barbara Whelan[SUP]6[/SUP] , Rapid Testing Expert Advisory Group, Ireland[SUP]7[/SUP]

We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation measure to reduce transmission of SARS-CoV-2. The tool aims to stratify, in real time, the overall risk of SARS-CoV-2 transmission associated with common activities and events, and this can be matched to an appropriate Ag-RDT testing protocol.

full article


https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.3.2101202

 

[sharon sanders]

bump this